Sentences with phrase «director of the vaccine research»

The team was led by Barton Haynes, M.D., director of the Duke Center for HIV / AIDS Vaccine Immunology - Immunogen Discovery (CHAVI - ID) and the Duke Human Vaccine Institute, and John Mascola, M.D., director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

«It's a nice tool to have in our arsenal,» says virologist Gary Nabel, director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland.

However, widespread vaccination «is going to be hard to justify,» argues Gary Nabel, director of the Vaccine Research Center at the National Institutes of Health in Bethesda, Md..

Not exact matches

Dr. Larry Corey, Principal Investigator, HIV Vaccine Trials Network; Past President and Director, Fred Hutchinson Cancer Research Center Dr. Diane Havlir, Professor of Medicine, University of California, San Francisco Moderator: Siobhan O'Connor, Time Magazine

Developing a vaccine against HIV is still our best hope for containing the AIDS pandemic, says Danilo Casimiro, Merck's director of basic vaccine research.

«Even with the new immunological studies, we can't tell what's special about the whole - cell vaccine that makes it better,» says Kathryn Edwards, the director of the Vanderbilt University School of Medicine Vaccine Research vaccine that makes it better,» says Kathryn Edwards, the director of the Vanderbilt University School of Medicine Vaccine Research Vaccine Research Center.

«Funding and commercial support are increasing in the area of vaccine R&D, especially because of the high investment by entities such as the NIH and the Bill & Melinda Gates Foundation,» noted Marie - Paule Kieny, director of the WHO's Initiative for Vaccine Revaccine R&D, especially because of the high investment by entities such as the NIH and the Bill & Melinda Gates Foundation,» noted Marie - Paule Kieny, director of the WHO's Initiative for Vaccine ReVaccine Research.

«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.

Maria Elena Bottazzi leads the research, education and administration efforts of the school, is a Professor of Pediatric Tropical Medicine and the Deputy Director for the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development.

A team of scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases, part of NIH, created VRC07 - αCD3 under the leadership of VRC Director John R. Mascola, M.D.; former VRC Director Gary J. Nabel, M.D., Ph.D.; and Richard A. Koup, M.D., VRC deputy director and chief of its immunology labDirector John R. Mascola, M.D.; former VRC Director Gary J. Nabel, M.D., Ph.D.; and Richard A. Koup, M.D., VRC deputy director and chief of its immunology labDirector Gary J. Nabel, M.D., Ph.D.; and Richard A. Koup, M.D., VRC deputy director and chief of its immunology labdirector and chief of its immunology laboratory.

Based at the Cancer Research Institute in New York, Old is the director of the Cancer Vaccine Collaborative, an international program dedicated to fighting cancer from the inside out.

One goal of the study is to demonstrate the prevalence of H. influenzae in the region, explains Joel Ward, director of the Center for Vaccine Research at the University of California, Los Angeles, and scientific adviser to IVI.

«An RSV vaccine with this M2 - 2 deletion could tip the balance toward a better immune response, which is what we predicted based on earlier laboratory studies,» says study leader Ruth A. Karron, MD, director of the Center for Immunization Research and a professor in the Department of International Health at the Bloomberg School.

Kosten is also researching vaccines for methamphetamines and opiates, which are among several anti-addiction shots that have the keen interest of the National Institute on Drug Abuse, says NIDA director Nora Volkow, a research psychiatrist who has used brain imaging to investigate the addictive properties of drugs.

Before the announcement, Marie - Paule Kieny, director of the World Health Organization's Initiative for Vaccine Research, told the news service: «I don't think that there is a lot of expectation that the efficacy of this vaccine will be very high.Vaccine Research, told the news service: «I don't think that there is a lot of expectation that the efficacy of this vaccine will be very high.vaccine will be very high.»

A summary of its recommendations, endorsed by WHO Director - General Margaret Chan on 11 July, was released in a statement today and discussed during a press briefing (audio file) by Marie - Paule Kieny, head of WHO's Initiative for Vaccine Research.

The research was led by the paper's senior author, James Crowe Jr., M.D., the Ann Scott Carrell Professor and director of the Vanderbilt Vaccine Center.

«We thought we would need five different sets of vaccines or five different (drugs),» said James Crowe Jr., M.D., the Ann Scott Carrell Professor and director of the Vanderbilt Vaccine Center, who led Vanderbilt's end of the research.

In a previously published paper, Barouch and colleagues, including Colonel Nelson L. Michael, MD, PhD, director of the Military HIV Research Program at the Walter Reed Army Institute of Research (WRAIR) and Stephen Thomas, MD, Upstate Medical University, State University of New York, demonstrated that three different vaccine candidates provided robust protection against Zika virus in both mice and rhesus monkeys.

Regulatory affairs is the name of the game at the FDA, in Washington, D.C., and the specialized aspect of reviewing and evaluating drugs or vaccines means there's significant training after hire, says Kathryn Carbone, associate director for research at the Center for Biologics Evaluation and Researchresearch at the Center for Biologics Evaluation and ResearchResearch (CBER).

«The pace of preclinical and early clinical development for Zika vaccines is unprecedented,» said Barouch, corresponding author and director of the Center for Virology and Vaccine Research at BIDMC.

«This is an important demonstration of the possibilities opened up for immunotherapy by DMAb technology to direct in vivo production of antibodies of major relevance to human cancer,» said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the study.

«Despite substantial public health efforts, flu vaccine rates for U.S. children are well below national targets,» says lead author Sarah J. Clark, M.P.H., associate director of the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health and associate research scientist in the U-M Department of Pediatrics.

«Taken together, these two studies suggest that the new scalable vaccine formulation is likely to prove as effective as the original formulation — which would make it the first protective TB vaccine in humans since BCG, which was introduced almost a century ago,» said Professor Ajit Lalvani, Director of the Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London and a member of the DAR - 901 development team.

«Many physicians reported tension between the need to build trust with families by being willing to compromise on the schedule while simultaneously feeling they were putting children at risk and causing them unnecessary pain by spreading out vaccines on multiple visits,» writes Allison Kempe, MD, MPH, professor of pediatrics and director of ACCORDS (Adult and Child Center for Health Outcomes Research and Delivery Science) at the University of Colorado School of Medicine and Children's Hospital Colorado.

«We previously showed that adenovirus vector - based HIV - 1 vaccine candidates offered partial protection against SIV when given alone,» said lead author Dan H. Barouch, M.D., Ph.D., director of the Center for Virology and Vaccine Research at BIDMC and professor of medicine at Harvard Medical vaccine candidates offered partial protection against SIV when given alone,» said lead author Dan H. Barouch, M.D., Ph.D., director of the Center for Virology and Vaccine Research at BIDMC and professor of medicine at Harvard Medical Vaccine Research at BIDMC and professor of medicine at Harvard Medical School.

«This vaccine is a successful advancement in developing control strategies for Zika virus by creating widespread immunity in susceptible populations,» said Stephen Higgs, director of the Biosecurity Research Institute.

But Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota in Minneapolis, says authorities should have been prepared to deploy the vaccine more quickly.

From that chat has arisen plans for the MSD Wellcome Trust Hilleman Laboratories — named after a vaccine scientist who worked at Merck — a non-profit research institute that it will act like a nimble biotech company with «dynamic decision - making» in the words of Ted Bianco, director of technology transfer at the Wellcome Trust.

As VRC Director, Dr. Mascola provides scientific leadership to the basic, clinical, and translational research activities of the VRC; develops vaccine research programs to meet public health needs; allocates VRC resources; and develops policies for the execution of multi-disciplinary research.

Dr. John Mascola is Director of the Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health.

William Schief is a Professor in the Immunology and Microbial Science Department at The Scripps Research Institute in La Jolla, CA, Director for Vaccine Design at the International AIDS Vaccine Initiative (IAVI), and an Associate Member of the Ragon Institute of MGH, MIT and Harvard.

David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center, and the W.W. Smith Endowed Chair in Cancer Research at The Wistar Institute, and peers received the 2018 Top Ten Clinical Research Achievement Award last night at the National Press Club in Washington, D.C.

Dr. Pontiano Kaleebu, Chairman Africa AIDS Vaccine Program and Acting Director of Uganda Virus Research Institute, delivered a strong keynote address that reiterated the importance of an HIV vaccine, what it will take to develop an effective vaccine and how community members can help with the international Vaccine Program and Acting Director of Uganda Virus Research Institute, delivered a strong keynote address that reiterated the importance of an HIV vaccine, what it will take to develop an effective vaccine and how community members can help with the international vaccine, what it will take to develop an effective vaccine and how community members can help with the international vaccine and how community members can help with the international effort.

«The two greatest challenges remaining in HIV / AIDS research are finding a cure and developing a safe and effective preventive vaccine,» said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which is leading the vaccine trial.

VIDD Director Dr. Julie McElrath has called the approach «the next wave» of HIV vaccine research.

Dr. Merlin Robb, Deputy Director of Clinical Research participated in a panel discussion entitled, «Progress Toward an HIV Vaccine.»

Since immune responses to vaccines can differ around the world, these findings are encouraging for the development of an effective Ebola vaccine for Africa,» said Merlin Robb, M.D., Director for Clinical Research at the US Military HIV Research Program (MHRP), whose site in Uganda, Makerere University Walter Reed Project (MUWRP), conducted the study.

He is the recipient of several awards and honors, including the NIH Director's Translational Research Award and the Vaccine Industry Association Outstanding Academic Research Laboratory.

There are many variations of H1N1, says Rafi Ahmed, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar, but this technology could be used to identify a very specific strain, such as the one weâ $ ™ re dealing with in the current pandemic.

«This finding is consistent with a hypothesis generated out of the follow - up studies to the RV144 HIV vaccine trial in Thailand that showed the first efficacy in humans,» noted COL Nelson Michael, Director of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research.

Weiner joined The Wistar Institute as the Executive Vice President, Director of the Vaccine & Immunotherapy Center, and W.W. Smith Charitable Trust Professor in Cancer Research in 2016.

Dr. Marie - Paule Kieny was Director of the WHO Initiative for Vaccine Research (IVR) from 2001 - 2010.

He was requested by Dr. Vasee Moorthy, Head of the WHO Initiative for Vaccine Research, and recommended for the WHO assignment team by Dr. Barney Graham, Deputy Director of the NIH Vaccine Research Center (VRC), and Colonel Nelson Michael, Director of the MHRP.

Glenda Gray, executive director of the Wits Health Consortium's perinatal HIV research unit in South Africa, presented data today at the HIV R4P conference in Cape Town indicating that the prime - boost vaccine candidates initially tested in the RV144 trial in Thailand — the only HIV vaccine trial to date to show any efficacy — induced cross-clade immune responses in a Phase I safety trial conducted in South Africa, with immunogenicity similar to or greater than that of the responses induced in Thai volunteers.

Old, who also heads the Ludwig Institute for Cancer Research (LICR) New York Branch and has served for many years as director of LICR's worldwide scientific programs, says that, eventually, vaccines will treat a wide variety of cancer types, recruiting the immune system to stop the progression of patients» tumors and helping to fully stabilizing the disease.

The Wistar Institute was awarded a $ 1,494,972 grant by the Bill & Melinda Gates Foundation to advance a DNA - based vaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Revaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer ReVaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Research.

«The approval of a vaccine to treat cancer is a victory in the history of cancer therapy, and signals the beginning of a new era in cancer medicine,» said Jill O'Donnell - Tormey, Ph.D., executive director of the U.S. - based Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that has provided decades of significant support to cancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be possible.

However, Gladstone Insitute of Virology and Immunology director, Warner Greene, says that a vaccine is still the Holy Grail in HIV research.

«A team of scientists here at NIAID worked tirelessly to rapidly develop this vaccine for clinical testing,» Dr. John Mascola, director of NIAID's Vaccine Research Center, said in the stavaccine for clinical testing,» Dr. John Mascola, director of NIAID's Vaccine Research Center, said in the staVaccine Research Center, said in the statement.